MedPath

Levothyroxine Sodium

LEVOTHYROXINE sodium for injection These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. LEVOTHYROXINE sodium for injection, for intravenous use Initial U.S. Approval: 1969

Approved
Approval ID

76139990-1355-cfb6-e053-2991aa0ace5b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 22, 2023

Manufacturers
FDA

Piramal Critical Care, Inc.

DUNS: 805600439

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levothyroxine Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66794-200
Application NumberANDA206163
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levothyroxine Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2023
FDA Product Classification

INGREDIENTS (4)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4B
Classification: IACT
LEVOTHYROXINE SODIUM ANHYDROUSActive
Quantity: 100 ug in 5 mL
Code: 054I36CPMN
Classification: ACTIB

Levothyroxine Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66794-201
Application NumberANDA206163
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levothyroxine Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2023
FDA Product Classification

INGREDIENTS (4)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4B
Classification: IACT
LEVOTHYROXINE SODIUM ANHYDROUSActive
Quantity: 500 ug in 5 mL
Code: 054I36CPMN
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levothyroxine Sodium - FDA Drug Approval Details